Adamas Pharmaceuticals, Inc. ROE 2014-2021 | ADMS
Current and historical return on equity (ROE) values for Adamas Pharmaceuticals, Inc. (ADMS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2021-09-30 | $-0.06B | $-0.02B | 360.00% |
| 2021-06-30 | $-0.06B | $-0.00B | 265.06% |
| 2021-03-31 | $-0.05B | $0.01B | 209.71% |
| 2020-12-31 | $-0.06B | $-0.05B | 185.60% |
| 2020-09-30 | $-0.06B | $-0.04B | 331.58% |
| 2020-06-30 | $-0.08B | $-0.02B | 1504.76% |
| 2020-03-31 | $-0.09B | $-0.02B | -808.70% |
| 2019-12-31 | $-0.11B | $-0.00B | -336.51% |
| 2019-09-30 | $-0.11B | $0.02B | -206.45% |
| 2019-06-30 | $-0.12B | $0.04B | -150.48% |
| 2019-03-31 | $-0.13B | $0.06B | -122.63% |
| 2018-12-31 | $-0.13B | $0.09B | -101.35% |
| 2018-09-30 | $-0.13B | $0.11B | -106.29% |
| 2018-06-30 | $-0.12B | $0.14B | -104.09% |
| 2018-03-31 | $-0.11B | $0.17B | -101.41% |
| 2017-12-31 | $-0.09B | $0.07B | -94.68% |
| 2017-09-30 | $-0.08B | $0.09B | -67.87% |
| 2017-06-30 | $-0.07B | $0.10B | -52.80% |
| 2017-03-31 | $-0.06B | $0.12B | -45.01% |
| 2016-12-31 | $-0.06B | $0.13B | -40.13% |
| 2016-09-30 | $-0.06B | $0.14B | -38.49% |
| 2016-06-30 | $-0.06B | $0.16B | -40.57% |
| 2016-03-31 | $-0.05B | $0.17B | -39.85% |
| 2015-12-31 | $-0.05B | $0.12B | -40.55% |
| 2015-09-30 | $-0.03B | $0.12B | -24.26% |
| 2015-06-30 | $-0.03B | $0.14B | -20.25% |
| 2015-03-31 | $0.00B | $0.14B | 1.43% |
| 2014-12-31 | $0.01B | $0.15B | 6.48% |
| 2014-09-30 | $0.02B | $0.13B | 20.80% |
| 2014-06-30 | $0.03B | $0.14B | 40.00% |
| 2014-03-31 | $0.01B | $0.07B | 26.67% |
| 2013-12-31 | $0.03B | $0.08B | 178.95% |
